Bonesupport

Bonesupport develops and markets an innovative range of radiopaque injectable osteoconductive and drug-eluting bioceramic products that have a proven ability to heal defects by remodeling to host bone in six to twelve months.

Bonesupport

CEO:

Emil Billbäck

First investment year:

2007

Business sector:

Life Science, Medtech

Investment manager: Marcus Skärbäck Visit website